ABC News' Dr. Tara Narula breaks down a potential non-surgical breakthrough as the FDA fast-tracks review of a ...

The implications are huge. Bladder cancer ranks as the sixth most common cancer in the U.S., affecting around 80,000 people ...

Lace up your runners for the 15th annual Canada Walks for Bladder Cancer! On September 20, 2025, we’ll gather at Saskatoon ...

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

By Dennis Thompson HealthDay ReporterMONDAY, Aug. 18, 2025 (HealthDay News) — A new implant eliminated bladder cancer in more ...

For people facing aggressive bladder cancer that no longer responds to standard treatment, options have often been ...

Natera (NTRA) recently reported positive topline results from the IMvigor011 clinical trial, demonstrating significant improvements in disease-free and overall survival for patients, which may ...

Roche has found redemption in a precision medicine approach following an earlier Tecentriq trial flop in a broader bladder ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...

For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained.

A new bladder cancer device called TAR-200 kept most patients cancer-free and surgery-free in a trial, with few side effects ...